Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Department of Pediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Kidney Blood Press Res. 2021;46(3):362-376. doi: 10.1159/000515823. Epub 2021 Jun 2.
Complement deposition is prevalent in kidney biopsies of patients with arterial hypertension and hypertensive nephropathy, but an association of hypertension and complement deposition or involvement of complement in the pathogenesis of hypertensive nephropathy has not been shown to date.
In this study, we analyzed complement C1q and C3c deposition in a rat model of overload and hypertension by subtotal nephrectomy (SNX) and in archival human renal biopsies from 217 patients with known hypertension and 91 control patients with no history of hypertension using semiquantitative scoring of C1q and C3c immunohistochemistry and correlation with parameters of renal function. To address whether complement was only passively deposited or actively expressed by renal cells, C1q and C3 mRNA expression were additionally analyzed.
Glomerular C1q and C3c complement deposition were significantly higher in kidneys of hypertensive SNX rats and hypertensive compared to nonhypertensive patients. Mean arterial blood pressure (BP) in SNX rats correlated well with the amount of glomerular C1q and C3c deposition and with left ventricular weight, as an indirect parameter of high BP. Quantitative mRNA analysis showed that C3 was not only deposited but also actively produced by glomerular cells of hypertensive SNX rats and in human renal biopsies. Of note, in patients CKD-stage correlated significantly with the intensity of glomerular C3c staining, but not with that of C1q.
Renal complement deposition correlated with experimental hypertension as well as the presence of hypertension in a variety of renal diseases. To answer the question, if and how exactly renal complement is causative for the pathogenesis of arterial hypertension in men, further studies are needed.
补体沉积在高血压和高血压肾病患者的肾活检中很常见,但高血压与补体沉积的相关性或补体在高血压肾病发病机制中的作用尚未得到证实。
在本研究中,我们通过部分肾切除术(SNX)分析了超重和高血压大鼠模型中的补体 C1q 和 C3c 沉积,并通过半定量评分分析了 217 例已知高血压患者和 91 例无高血压病史的对照患者的存档人类肾活检组织中的补体 C1q 和 C3c 免疫组织化学,并与肾功能参数相关。为了解补体是否仅被动沉积或由肾细胞主动表达,还分析了 C1q 和 C3 mRNA 表达。
高血压 SNX 大鼠和高血压患者的肾小球 C1q 和 C3c 补体沉积明显高于非高血压患者。SNX 大鼠的平均动脉压(BP)与肾小球 C1q 和 C3c 沉积量以及左心室重量密切相关,左心室重量是高血压的间接参数。定量 mRNA 分析表明,C3 不仅沉积,而且在高血压 SNX 大鼠的肾小球细胞和人类肾活检组织中也被主动产生。值得注意的是,在患者中,CKD 分期与肾小球 C3c 染色的强度显著相关,但与 C1q 的强度无关。
肾脏补体沉积与实验性高血压以及各种肾脏疾病中存在的高血压相关。为了回答在男性中肾脏补体是否以及如何确切地导致动脉高血压发病机制的问题,还需要进一步的研究。